The LSE Directory / Charting platforms
MarketSurge is the flagship charting and stock-research platform published by Investor's Business Daily (IBD). It pairs interactive price charts with a proprietary 1-99 rating system, scoring stocks on earnings growth, sales acceleration, profit margins, return on equity and relative price strength, and layers on curated stock lists such as the IBD 50, pre-built screens like Recent Breakouts, and model portfolios built around founder William O'Neil's CAN SLIM growth-investing methodology. An AI-assisted Pattern Recognition tool overlays chart formations, cup-with-handle, flat base, double bottom, directly on the price chart with color-coded buy, profit and loss zones, and the platform includes a customizable stock and ETF screener covering technical and fundamental data points alongside earnings history and institutional-ownership tracking. MarketSurge targets active swing and growth-stock traders who already work within, or want to adopt, the CAN SLIM framework, rather than passive investors, options traders or broker-execution users. Its differentiation from general-purpose charting tools is methodological rather than purely technical: nearly every feature, the ratings, the pattern flags, the checklists, is built to operationalize O'Neil's specific rules for buying and selling growth stocks, which makes it deep for that one style and comparatively narrow outside it. Independent reviews commonly frame it as a premium, workflow-specific tool priced well above general screener or charting competitors, aimed at traders committed to that discipline rather than casual users. Investor's Business Daily was founded in 1984 by William O'Neil (originally as Investor's Daily, renamed Investor's Business Daily in 1991) as a financial newspaper built around the scarcity of usable stock data in mainstream press. In March 2021, News Corp agreed to acquire IBD from O'Neil Capital Management for 275 million dollars, folding it into its Dow Jones & Company division while keeping it a standalone, Los Angeles-based brand; at the time of the deal IBD had roughly 130 employees and close to 100,000 digital subscribers, with more than 90 percent of its revenue already coming from digital products. MarketSurge itself launched in March 2024 as a rebuild and rebrand of IBD's earlier MarketSmith platform, migrating existing MarketSmith subscribers and their saved data while adding features such as an Earnings Line chart overlay, an institutional-accumulation indicator associated with trader David Ryan, and forward earnings estimates. As of 2026, MarketSurge is sold on a subscription basis, with a six-week trial around 49.95 dollars, a monthly plan around 149.95 dollars, and an annual plan around 1,499 dollars a year, positioning it as one of the more expensive retail charting and research subscriptions in its category.
